Insight Folios Inc Purchases 345 Shares of CVS Health Co. (NYSE:CVS)

Insight Folios Inc increased its position in shares of CVS Health Co. (NYSE:CVS) by 4.5% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 8,068 shares of the pharmacy operator’s stock after acquiring an additional 345 shares during the period. Insight Folios Inc’s holdings in CVS Health were worth $644,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Axxcess Wealth Management LLC lifted its position in CVS Health by 150.1% in the 3rd quarter. Axxcess Wealth Management LLC now owns 20,552 shares of the pharmacy operator’s stock valued at $1,435,000 after acquiring an additional 12,334 shares in the last quarter. Alps Advisors Inc. grew its position in CVS Health by 325.1% during the third quarter. Alps Advisors Inc. now owns 21,174 shares of the pharmacy operator’s stock valued at $1,478,000 after acquiring an additional 16,193 shares during the last quarter. Adage Capital Partners GP L.L.C. raised its position in CVS Health by 14.4% in the 3rd quarter. Adage Capital Partners GP L.L.C. now owns 1,461,505 shares of the pharmacy operator’s stock worth $102,042,000 after purchasing an additional 184,231 shares during the period. Lake Street Advisors Group LLC lifted its stake in shares of CVS Health by 2.4% in the 3rd quarter. Lake Street Advisors Group LLC now owns 13,048 shares of the pharmacy operator’s stock valued at $911,000 after acquiring an additional 311 shares during the last quarter. Finally, Key Client Fiduciary Advisors LLC raised its holdings in CVS Health by 16.0% during the 3rd quarter. Key Client Fiduciary Advisors LLC now owns 6,192 shares of the pharmacy operator’s stock valued at $432,000 after buying an additional 854 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Baird R W raised CVS Health to a “hold” rating in a research report on Thursday, May 30th. Barclays reduced their price objective on shares of CVS Health from $78.00 to $63.00 and set an “equal weight” rating on the stock in a research report on Thursday, May 2nd. Piper Sandler raised their target price on shares of CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, March 15th. Leerink Partnrs cut shares of CVS Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 1st. Finally, UBS Group lowered shares of CVS Health from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $85.00 to $60.00 in a report on Thursday, May 2nd. Eleven analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $75.05.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Edward J. Ludwig purchased 1,000 shares of the stock in a transaction dated Thursday, May 2nd. The shares were purchased at an average cost of $53.88 per share, with a total value of $53,880.00. Following the completion of the acquisition, the director now directly owns 21,630 shares in the company, valued at approximately $1,165,424.40. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 0.24% of the company’s stock.

CVS Health Stock Down 1.4 %

CVS Health stock traded down $0.82 during mid-day trading on Thursday, reaching $56.70. The stock had a trading volume of 5,371,350 shares, compared to its average volume of 10,197,653. The company has a market capitalization of $71.18 billion, a price-to-earnings ratio of 9.96, a PEG ratio of 0.55 and a beta of 0.52. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The company has a 50-day moving average price of $58.89 and a two-hundred day moving average price of $69.81.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.69 by ($0.38). The firm had revenue of $88.44 billion during the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The company’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.20 EPS. On average, analysts expect that CVS Health Co. will post 7.02 EPS for the current fiscal year.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.